132 related articles for article (PubMed ID: 8871668)
1. Molecular characterization of properdin deficiency type III: dysfunction produced by a single point mutation in exon 9 of the structural gene causing a tyrosine to aspartic acid interchange.
Fredrikson GN; Westberg J; Kuijper EJ; Tijssen CC; Sjöholm AG; Uhlén M; Truedsson L
J Immunol; 1996 Oct; 157(8):3666-71. PubMed ID: 8871668
[TBL] [Abstract][Full Text] [Related]
2. Sequence-based analysis of properdin deficiency: identification of point mutations in two phenotypic forms of an X-linked immunodeficiency.
Westberg J; Fredrikson GN; Truedsson L; Sjöholm AG; Uhlén M
Genomics; 1995 Sep; 29(1):1-8. PubMed ID: 8530058
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies.
van den Bogaard R; Fijen CA; Schipper MG; de Galan L; Kuijper EJ; Mannens MM
Eur J Hum Genet; 2000 Jul; 8(7):513-8. PubMed ID: 10909851
[TBL] [Abstract][Full Text] [Related]
4. Carrier detection in families with properdin deficiency by microsatellite haplotyping.
Kölble K; Cant AJ; Fay AC; Whaley K; Schlesinger M; Reid KB
J Clin Invest; 1993 Jan; 91(1):99-102. PubMed ID: 8423238
[TBL] [Abstract][Full Text] [Related]
5. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
6. Expression of properdin in complete and incomplete deficiency: normal in vitro synthesis by monocytes in two cases with properdin deficiency type II due to distinct mutations.
Fredrikson GN; Gullstrand B; Westberg J; Sjöholm AG; Uhlén M; Truedsson L
J Clin Immunol; 1998 Jul; 18(4):272-82. PubMed ID: 9710744
[TBL] [Abstract][Full Text] [Related]
7. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
Zhang DL; Ji L; Li YD
Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
[TBL] [Abstract][Full Text] [Related]
8. Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis.
Bathum L; Hansen H; Teisner B; Koch C; Garred P; Rasmussen K; Wang P
Mol Immunol; 2006 Feb; 43(5):473-9. PubMed ID: 16337490
[TBL] [Abstract][Full Text] [Related]
9. Properdin deficiency in a family with fulminant meningococcal infections.
Sjöholm AG; Braconier JH; Söderström C
Clin Exp Immunol; 1982 Nov; 50(2):291-7. PubMed ID: 7151327
[TBL] [Abstract][Full Text] [Related]
10. Characterization of mutant forms of recombinant human properdin lacking single thrombospondin type I repeats. Identification of modules important for function.
Higgins JM; Wiedemann H; Timpl R; Reid KB
J Immunol; 1995 Dec; 155(12):5777-85. PubMed ID: 7499866
[TBL] [Abstract][Full Text] [Related]
11. Further mapping of the properdin deficiency gene in a Tunisian Jewish family--evidence for genetic homogeneity.
Ash S; Johnson C; Shohat M; Shohat T; Schlesinger M
Isr J Med Sci; 1994 Aug; 30(8):626-8. PubMed ID: 8045746
[TBL] [Abstract][Full Text] [Related]
12. The human complement C9 gene: identification of two mutations causing deficiency and revision of the gene structure.
Witzel-Schlömp K; Späth PJ; Hobart MJ; Fernie BA; Rittner C; Kaufmann T; Schneider PM
J Immunol; 1997 May; 158(10):5043-9. PubMed ID: 9144525
[TBL] [Abstract][Full Text] [Related]
13. [Properdin deficiency].
Kira R; Hara T
Ryoikibetsu Shokogun Shirizu; 2000; (32):223-5. PubMed ID: 11212699
[No Abstract] [Full Text] [Related]
14. Genetic characterization of protein C deficiency in Japanese subjects using a rapid and nonradioactive method for single-stand conformational polymorphism analysis and a model building.
Miyata T; Sakata T; Zheng YZ; Tsukamoto H; Umeyama H; Uchiyama S; Ikusaka M; Yoshioka A; Imanaka Y; Fujimura H; Kambayashi J; Kato H
Thromb Haemost; 1996 Sep; 76(3):302-11. PubMed ID: 8883262
[TBL] [Abstract][Full Text] [Related]
15. Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency.
Iacobazzi V; Invernizzi F; Baratta S; Pons R; Chung W; Garavaglia B; Dionisi-Vici C; Ribes A; Parini R; Huertas MD; Roldan S; Lauria G; Palmieri F; Taroni F
Hum Mutat; 2004 Oct; 24(4):312-20. PubMed ID: 15365988
[TBL] [Abstract][Full Text] [Related]
16. Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: no evidence for mutations in familial hyperaldosteronism type II in a large affected kindred.
Elphinstone MS; Gordon RD; So A; Jeske YW; Stratakis CA; Stowasser M
Clin Endocrinol (Oxf); 2004 Dec; 61(6):716-23. PubMed ID: 15579186
[TBL] [Abstract][Full Text] [Related]
17. Abnormal propeptide processing resulting in the presence of two abnormal species of protein C in plasma: characterization of the dysfunctional protein C Padua3 (protein C(R-1L/propeptide)).
Simioni P; Kalafatis M; Tormene D; Luni S; Zerbinati P; Barzon L; Palù G; Girolami A
Thromb Haemost; 2001 Oct; 86(4):1017-22. PubMed ID: 11686318
[TBL] [Abstract][Full Text] [Related]
18. Properdin deficiency.
Lancet; 1988 Jan; 1(8577):95-6. PubMed ID: 2891989
[No Abstract] [Full Text] [Related]
19. Recurrent missense (R197C) and nonsense (Y89X) mutations in the XLRS1 gene in families with X-linked retinoschisis.
Shastry BS; Hejtmancik FJ; Trese MT
Biochem Biophys Res Commun; 1999 Mar; 256(2):317-9. PubMed ID: 10079181
[TBL] [Abstract][Full Text] [Related]
20. Human properdin deficiency has a heterogeneous genetic background.
Truedsson L; Westberg J; Fredrikson GN; Sjöholm AG; Kuijper EJ; Fijen CA; Späth PJ; Uhlén M
Immunopharmacology; 1997 Dec; 38(1-2):203-6. PubMed ID: 9476131
[No Abstract] [Full Text] [Related]
[Next] [New Search]
